Brief: Glaukos Receives Permanent J-Code For Idose® TR (Travoprost Intracameral Implant)
03/04/2024 12:12
April 3 (Reuters) - Glaukos Corp GKOS.N :
* GLAUKOS RECEIVES PERMANENT J-CODE FOR IDOSE® TR
(TRAVOPROST
INTRACAMERAL IMPLANT)
* GLAUKOS CORP - NEW J-CODE FOR IDOSE TR(®), J7355, SET TO
BECOME
EFFECTIVE JULY 1, 2024
Source text for Eikon: ID:nBwbXDyNYa
Further company coverage: GKOS.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Glaukos
See all newsGlaukos says late-stage eye disease treatment shows lasting benefits after single dose
Brief: Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes In Keratoconus
US RESEARCH ROUNDUP-Boeing, Twilio, WP Carey
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Glaukos Corp reports results for the quarter ended June 30 - Earnings Summary